Protocol design does not struggle in the protocol. It struggles in the transition to trial, when assumptions embedded in the ...

In today's ACT Brief, we examine quantified reductions in trial visits through selective safety data collection, why protocol ...

Microsoft 365 Copilot deployment aims to automate high-volume, repeatable work, freeing clinical operations staff for ...

In today's ACT Brief, we recap key themes from DIA 2026 on operational priorities and regulatory shifts, examine ...

FDA proof-of-concept trials with AstraZeneca and Amgen validate continuous data transmission and signal detection, setting ...

In today's ACT Brief, we examine what the FDA's real-time oversight initiative demands of sponsors, why clinical data ...

Authoritative coverage across the full spectrum of clinical trial operations — strategic insights, regulatory guidance, and practical solutions for the ...

In today's ACT Brief, we examine regulatory uncertainty and 2026 breakthroughs shaping clinical research, reimagining CRO ...

This article argues that improving financial outcomes—including more reliable revenue recognition—requires revisiting the ...

In today's ACT Brief, we examine HHS coordinated effort to restore US clinical research leadership, two decades of rising ...

In this video interview following the 2026 DIA Global Annual Meeting, Jonathan Andrus, co-CEO of CRIO, explains why ...